Form 4: Colgate-Palmolive Director Receives Stock Grants

Colgate-Palmolive director Martin C. Harris received stock grants and options as part of the company's annual incentive compensation plan.

Summary

• Director Martin C. Harris was granted 1,556 shares of common stock on May 11, 2026, valued at $0.0000.
• Following this transaction, Mr. Harris beneficially owns 24,517 shares of common stock.
• Additionally, Mr. Harris was granted stock options to purchase 2,424 shares of common stock with an exercise price of $86.74.
• These options vest in equal annual installments over three years, starting on the first anniversary of the grant date (May 11, 2026).
• The options are exercisable until May 11, 2034.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine director compensation rather than significant financial performance or strategic shifts.

Positives

• Director compensation through stock grants and options aligns management's interests with shareholders.
• The grant of stock options indicates a belief in future stock price appreciation.
• Vesting schedule for options encourages long-term commitment from the director.

Negatives

• The reported value of the stock grant is $0.0000, which may require further clarification on the actual economic value or accounting treatment.

Future Outlook

The stock options granted have an exercise price of $86.74 and vest over three years, suggesting an expectation of future stock price performance that would make exercising these options beneficial.

Industry Context

StockSavvy.ai notes that director compensation through equity awards is a standard practice in the consumer staples industry, aiming to align executive and director interests with long-term shareholder value.

Related Party Transactions

• The filing details a stock grant and stock option grant to Director Martin C. Harris, which are standard forms of compensation for directors.

Stakeholder Impact

• Shareholders: The alignment of director compensation with stock performance can be viewed positively, as it incentivizes directors to act in the best interest of shareholders.
• Employees: Standard compensation practices for directors do not typically have a direct impact on employees.

Next Steps

• Director Martin C. Harris will receive annual installments of stock options over three years.
• The stock options become exercisable starting May 11, 2027.

Key Dates

Keywords

Form 4, SEC Filing, Colgate-Palmolive, Director Compensation, Stock Grant, Stock Options, Beneficial Ownership, Insider Trading